ONCY

#3917
Oncolytics Biotech, Inc. Common Shares
1.06 USD
+3.92%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.04
1.06
Range Annuel
0.33
1.51
Changement quotidien
+3.92%
Changement Mensuel
+7.07%
Evolution sur 6 mois
-13.11%
Changement Annuel
+82.76%
Clôture Précédente
1.02
Open
1.05
Bid
Ask
Low
1.04
High
1.06
Volume
42
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q4, 25 TTM

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Nouvelles